págs. 695-701
Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives
págs. 702-712
Cancer immunotherapy of patients with HIV infection
María González Cao, Javier Martínez-Picado, N. Karachaliou, Rafael Rosell Costa, A. Meyerhans
págs. 713-720
Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients’ preference-based study (PPPS)
Y. Zhao, G. Qiao, Xiaoli Wang, Y. Song, X. Zhou, N. Jiang, L. Zhou, H. Huang, J. Zhao, Michael Morse, A. Hobeika, Jun Ren, Herbert Kim Lyerly
págs. 721-728
págs. 729-734
Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)
Felipe Couñago Lorenzo, S. Montemuiño, M. Martín, Begoña Taboada Valladares, Patricia Calvo Crespo, Pilar Samper Ots, Pino Alcántara Carrió, Juan Antonio Corona Sánchez, José Luis López Guerra, Mauricio Murcia Mejía, M. López Mata, J. Jové Teixidó, M. L. Chust Vicente, V. Díaz Díaz, L. de Ingunza Barón, Tamara García Cañibano, M.L. Couselo Paniagua, Elia del Cerro Peñalver, F.J. Moradiellos Díez, Sergio Amor-Alonso, Andrés Varela de Ugarte, M. M. Puertas, Israel John Thuissard Vasallo, David Sanz Rosa, Núria Rodríguez de Dios
págs. 735-744
The protective effects of melatonin on blood cell counts of rectal cancer patients following radio-chemotherapy: a randomized controlled trial
N. Kouhi Habibi, A. Shabestani Monfared, K. Ebrahimnejad Gorji, M. Karimi, A.A. Moghadamnia, M. Tourani, S. Borzoueisileh, F. Niksirat
págs. 745-752
págs. 753-759
págs. 760-765
Diagnostic performance of 18F-choline PET-CT in prostate cancer
Pilar Samper Ots, A. Luis Cardo, Carmen Vallejo Ocaña, M.A. Cabeza Rodríguez, Luis Alberto Glaría Enríquez, M.L. Couselo Paniagua, Jesús Olivera Vegas
págs. 766-773
M. Bloemendal, M.J.A. Rietveld, W.W. van Willigen, W.R. Gerritsen, Carl G. Figdor, J.J. Bonenkamp, H. Westdorp, S. Boudewijns, R.H.T. Koornstra, Eddy M.M. Adang, G. Schreibelt, P.B. Ottevanger, I. J. M. de Vries, K.F. Bol
págs. 774-780
págs. 781-789
Metronomic oral vinorelbine for the treatment of advanced non-small cell lung cancer: a multicenter international retrospective analysis
A. Camerini, G.L. Banna, S. Cinieri, A. Pezzuto, M. Mencoboni, F. Rosetti, Ana Figueiredo, P. Rizzo, A. Ricci, L. Langenhoven, A. Santo, A. Addeo, D. Amoroso, F. Barata
págs. 790-795
R. Escudero Ávila, J.D. Rodríguez Castaño, Ignacio Osman García, F. Fernandez, Rafael A. Medina López, Blanca Vargas Serrano, Miguel Ángel Japón Rodríguez, Pilar Sancho, B. Pérez Valderrama, JM Praena-Fernández, Ignacio Durán Martínez
págs. 796-804
Improvement of appropriate pharmacological prophylaxis in hospitalised cancer patients with a multiscreen e-alert system: a single-centre experience
María del Rocío Figueroa Mora, Ana Alfonso Piérola, José María López-Picazo González, Ignacio Gil-Bazo, Alberto García Mouriz, José Hermida Santos, José Antonio Páramo Fernández, Ramón Lecumberri
págs. 805-809
Statin treatment and outcomes of metastatic pancreatic cancer: a pooled analysis of two phase III studies
págs. 810-816
© 2001-2024 Fundación Dialnet · Todos los derechos reservados